Reuters reported that Novo Nordisk launched Wegovy in India in June 2025, and the lower doses were priced around 17,345 per month , with higher monthly costs for stronger doses
"Critically, when dysfunction is driven primarily by psychosocial factors, such as relationship distress, pharmacotherapy (medication) alone is unlikely to succeed." In his own practice, Balazs reported seeing "both ends," although most of his patients have improved sex lives
If these mechanisms translate consistently into humans, this could reshape how we think about patient selection and treatment goalsespecially in individuals who may not achieve substantial weight reduction but still derive meaningful hepatic benefit
Dihexa exhibits excellent antidementia activity in the scopolamine and aged rat models and marked synaptogenic activity
Key Takeaways The question our licensed nurse injectors hear most from patients starting a GLP-1 program is some version of the same thing: does it matter where I inject? The answer is that the site you choose matters less than what you do with it over time
Human safety data for injectable KPV is community-source-dominated
